Further support for the NOD2/RIPK2 pathway was demonstrated recently in a report documenting the presence of a germline mutation in RIPK2 that resulted in a constitutively active form of RIPK2 in osteoarthritis patients [51]. The gene discussed is RIPK2; the disease is osteoarthritis.